Research shows 53 per cent of Australians never consult a GP for hay fever advice
Dr Ginni Mansberg ambassador for ‘Tried-It-All’ hay fever campaign launched today
Press releases
These press releases are intended for business journalists and analysts/investors
GSK and Sun Pharma complete Opiates transaction
Read more - GSK and Sun Pharma complete Opiates transaction Read more
GSK's parting gifts to local community
Read more - GSK's parting gifts to local community Read more
Pharmacy Level Recall - Bactroban® Cream (mupirocin calcium 2%) and Bactroban® Nasal Ointment (mupirocin calcium 2%)
Recall of five batches of Bactroban Cream and three batches of Bactroban Nasal Ointment
GSK’s malaria candidate vaccine, MosquirixTM (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
WHO will now assess how the world’s first malaria candidate vaccine might be used alongside other tools to prevent malaria
Update on supply of Zovirax Ophthalmic Ointment (aciclovir 3%)
Zovirax Ophthalmic Ointment (aciclovir 3%) is impacted by an ongoing global supply constraint with no confirmed resupply date in Australia.
Read more - Update on supply of Zovirax Ophthalmic Ointment (aciclovir 3%) Read more
INTERNATIONAL MEN’S HEALTH WEEK 2015: Sam Newman exposes neglected men’s health issue
Australian campaign focuses on enlarged prostates
GSK Australia releases 2014 Responsible Business Report
GSK Australia and New Zealand have published the third annual responsible business report, outlining key achievements in health, community and environmental sustainability.
Read more - GSK Australia releases 2014 Responsible Business Report Read more
GSK Australia launches new vaccination picture book for Aboriginal and Torres Strait Islanders
GSK Australia has a new immunisation resource for Aboriginal and Torres Strait Islanders this month to encourage families to be proactive when it comes to immunising themselves and their children against preventable diseases.
GSK granted $1 million by Federal Government for advanced manufacturing project in Boronia
GSK Australia is a recipient of a grant through of the Federal Government’s Manufacturing Transition Programme worth AUD$1 million. Funding will support GSK’s advanced manufacturing expansion plans at its Boronia site which focus on new product development using innovative “Blow-Fill-Seal” (BFS) technology.